Alkermes deal

Boehringer Mannheim GmbH will apply ALKS's ProLease sustained release drug delivery technology to up to four Boeh-ringer molecules. ProLease consists of biocompatible and biodegradable microspheres of polylactic acid/glycolic acid that are impregnated with a drug and injected, releasing the drug over a sustained period. ...